Clinicopathological study of myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis

Clin Nephrol. 1999 Nov;52(5):293-6.

Abstract

Aims: To investigate the potential prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.

Materials: The clinical and pathological findings were reviewed in 17 patients with this type of glomerulonephritis.

Methods: The relationship between the outcome and various clinical and pathological factors were assessed. The relationship between the blood MPO-ANCA level and cellular crescent formation was also investigated.

Results: Patients who died had a significantly lower serum albumin and creatinine clearance than those who survived, but there were no differences of age, blood MPO-ANCA, urinary protein, and serum creatinine levels or cellular crescent formation between the two groups. There was a close relationship between blood MPO-ANCA levels and cellular crescent formation.

Conclusions: Hypoalbuminemia and renal dysfunction may be indicators of a poor prognosis in MPO-ANCA-associated glomerulonephritis. Patients with high blood levels of this antibody and increased cellular crescent formation appear to have active disease, but these factors are not statistically associated with a fatal outcome. Therefore, aggressive treatment may be indicated in patients with active disease initially.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Antineutrophil Cytoplasmic / analysis*
  • Creatinine / blood
  • Female
  • Glomerulonephritis / immunology
  • Glomerulonephritis / metabolism
  • Glomerulonephritis / pathology*
  • Glomerulonephritis / therapy
  • Humans
  • Kidney Glomerulus / pathology
  • Male
  • Middle Aged
  • Peroxidase / immunology*
  • Prognosis
  • Proteinuria
  • Serum Albumin / analysis
  • Treatment Outcome

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Serum Albumin
  • Creatinine
  • Peroxidase